Commonwealth Equity Services’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$149K Buy
72,120
+4,819
+7% +$9.96K ﹤0.01% 3993
2025
Q1
$148K Sell
67,301
-925
-1% -$2.03K ﹤0.01% 3920
2024
Q4
$104K Buy
68,226
+4,550
+7% +$6.94K ﹤0.01% 3898
2024
Q3
$127K Buy
63,676
+6,925
+12% +$13.8K ﹤0.01% 3826
2024
Q2
$199K Sell
56,751
-281,775
-83% -$988K ﹤0.01% 3639
2024
Q1
$938K Buy
338,526
+10,122
+3% +$28K ﹤0.01% 2303
2023
Q4
$558K Buy
328,404
+13,578
+4% +$23.1K ﹤0.01% 2611
2023
Q3
$324K Buy
314,826
+16,467
+6% +$16.9K ﹤0.01% 2958
2023
Q2
$346K Buy
298,359
+278,497
+1,402% +$323K ﹤0.01% 2928
2023
Q1
$29 Sell
19,862
-750
-4% -$1 ﹤0.01% 3633
2022
Q4
$51K Sell
20,612
-525
-2% -$1.3K ﹤0.01% 3515
2022
Q3
$89K Buy
21,137
+4,615
+28% +$19.4K ﹤0.01% 3392
2022
Q2
$46K Buy
16,522
+5,000
+43% +$13.9K ﹤0.01% 3498
2022
Q1
$65K Sell
11,522
-80
-0.7% -$451 ﹤0.01% 3552
2021
Q4
$105K Sell
11,602
-19,458
-63% -$176K ﹤0.01% 3443
2021
Q3
$332K Sell
31,060
-371
-1% -$3.97K ﹤0.01% 2816
2021
Q2
$487K Buy
31,431
+516
+2% +$8K ﹤0.01% 2489
2021
Q1
$501K Buy
30,915
+3,706
+14% +$60.1K ﹤0.01% 2331
2020
Q4
$575K Sell
27,209
-819
-3% -$17.3K ﹤0.01% 2054
2020
Q3
$415K Sell
28,028
-2,067
-7% -$30.6K ﹤0.01% 2097
2020
Q2
$442K Buy
30,095
+13,506
+81% +$198K ﹤0.01% 1972
2020
Q1
$194K Buy
16,589
+4,339
+35% +$50.7K ﹤0.01% 2409
2019
Q4
$287K Buy
12,250
+200
+2% +$4.69K ﹤0.01% 2356
2019
Q3
$222K Buy
+12,050
New +$222K ﹤0.01% 2478